Clinical Trial Update: Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC [Phase 1]

View source ↗

Summary

Phase 1 trial of atezolizumab and varlilumab with radiation therapy in refractory stage IV non-small cell lung cancer was terminated, with results posted in Jun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Varlilumab (varlilumab)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Refractory Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 1 | Status: TERMINATED | Results posted: 2023-06-02